url:https://finance.yahoo.com/m/495cdbeb-81c1-3020-8ea7-2143f3daa6bb/fda-advisors-review-crispr.html
title:FDA_Advisors_Review_Crispr_GeneEditing_Treatment_for_Sickle_Cell_Anemia
One after another, the men and women testified how a new gene-editing treatment had relieved their suffering from sickle-cell disease. Sickle cell has afflicted people of African descent for generations, causing agony and death among those who inherit its deformed red blood cells. At the daylong meeting, the FDA empaneled outside experts to review the gene-editing treatment, before the agency makes an approval decision.